Home

Syngene International Ltd PE Ratio

Image

Syngene International Ltd

NSE: SYNGENE

PE

71.9

Last updated on: Jan 13, 2025

Key Highlights

  • The P/E Ratio of Syngene International Ltd is 71.9 as of 13 Jan 9.00 AM .
  • The P/E Ratio of Syngene International Ltd changed from 23.5 on March 2020 to 55.3 on March 2024 . This represents a CAGR of 18.67% over 5 years.
  • The Latest Trading Price of Syngene International Ltd is ₹ 823.3 as of 13 Jan 15:30 .
  • The PE Ratio of Healthcare Industry has changed from 34.6 to 62.9 in 5 years. This represents a CAGR of 12.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.9. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Syngene International Ltd

No data available

Company Fundamentals for Syngene International Ltd

Image

Syngene International Ltd

NSE: SYNGENE

Share Price

₹ 823.3

-35.85 (-4.17%)

stock direction

Last updated on: Jan 13, 2025

Market Price of Syngene International Ltd

1M

1Y

3Y

5Y

Monitoring Syngene International Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Jan 2025823.3
10 Jan 2025859.15
09 Jan 2025876.9
08 Jan 2025871.65
07 Jan 2025877.75
06 Jan 2025862.9
03 Jan 2025857.5
02 Jan 2025872.95
01 Jan 2025878.35
31 Dec 2024858.05

SWOT Analysis Of Syngene International Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Syngene International Ltd

Asset Value vs Market Value of Syngene International Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Syngene International Ltd33140
Max Healthcare Institute Ltd105228
Apollo Hospitals Enterprise Ltd98332
Fortis Healthcare Ltd50088
Global Health Ltd27627

PE Ratio of Syngene International Ltd Explained

``

33140

Market cap

481

Earnings

71.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Syngene International Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Syngene International Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Syngene International Ltd

No data available

* All values are in %

About Syngene International Ltd

  • Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
  • Headquartered in India, the operations are driven by its highly qualified teams comprising ~6000 scientists and its state-of-the-art facilities, spread over 2.2 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
  • The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
  • The Company's health-related services extend across all major therapeutic areas and modalities.

Syngene International Ltd News Hub

Syngene International to convene board meeting

Syngene International will hold a meeting of the Board of Directors of the Company on 23 October 202

Read more

2024-10-05 00:00:00

Syngene International consolidated net profit declines 8.93% in the September 2024 quarter

Net profit of Syngene International declined 8.93% to Rs 106.10 crore in the quarter ended September

Read more

2024-10-23 00:00:00

Board of Syngene International approves change in management

The Board of Syngene International at its meeting held on 23 October 2024 has approved the following

Read more

2024-10-23 00:00:00

Volumes jump at Syngene International Ltd counter

Varroc Engineering Ltd, Piramal Enterprises Ltd, Anupam Rasayan India Ltd, Metropolis Healthcare Ltd

Read more

2024-12-10 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Syngene International Ltd

What is the current PE Ratio of Syngene International Ltd?

The Current PE Ratio of Syngene International Ltd is 71.9 as on 13 Jan 2025.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 62.9 as on 13 Jan 2025.

What was the PE Ratio of Syngene International Ltd last year?

The PE Ratio of Syngene International Ltd was 51.39 last year, now the PE ratio is 71.9, showing a year-on-year growth of 39.9%.

What does the PE Ratio of Syngene International Ltd indicate about its stock?

The PE Ratio of Syngene International Ltd is 71.9. This ratio indicates that investors are willing to pay 71.9 times the earnings per share for each share of Syngene International Ltd.

What is the PE Ratio Growth of Syngene International Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Syngene International Ltd grew by 39.9% whereas, the EPS ratio grew by 39.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions